{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:36:49Z","timestamp":1784875009592,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Popul Health Metrics"],"DOI":"10.1186\/s12963-026-00469-2","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T13:13:08Z","timestamp":1772975588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reframing disease burden: validation of DALY-per-case as a per-diagnosis severity metric"],"prefix":"10.1186","volume":"24","author":[{"given":"Omar","family":"Freihat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"key":"469_CR1","unstructured":"GBD 2021, Global Burden of Disease Study 2021 (GBD 2021) Results, Seattle, WA, 2021. Accessed: Mar. 21, 2025. [Online]. Available: https:\/\/vizhub.healthdata.org\/gbd-results"},{"issue":"3","key":"469_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"469_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/eurpub\/ckq120","volume":"21","author":"F Asadzadeh Vostakolaei","year":"2011","unstructured":"Asadzadeh Vostakolaei F, Karim-Kos HE, Janssen-Heijnen MLG, Visser O, Verbeek ALM, Kiemeney LALM. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health. 2011;21(5):573\u20137. https:\/\/doi.org\/10.1093\/eurpub\/ckq120.","journal-title":"Eur J Public Health"},{"issue":"3","key":"469_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019 a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420\u201344. https:\/\/doi.org\/10.1001\/jamaoncol.2021.6987.","journal-title":"JAMA Oncol."},{"key":"469_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356\u201387. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.005.","journal-title":"Eur. J. Cancer"},{"issue":"Supplement_1","key":"469_CR6","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017. Neuro-Oncol. 2020;22(Supplement_1):iv1\u201396. https:\/\/doi.org\/10.1093\/neuonc\/noaa200.","journal-title":"Neuro-Oncol"},{"issue":"1","key":"469_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03342-3","volume":"19","author":"CC Oliveira","year":"2024","unstructured":"Oliveira CC, et al. A systematic review of studies that estimated the burden of chronic non-communicable rare diseases using disability-adjusted life years. Orphanet J Rare Dis. 2024;19(1):333. https:\/\/doi.org\/10.1186\/s13023-024-03342-3.","journal-title":"Orphanet J. Rare Dis."},{"key":"469_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jclinepi.2021.10.018","volume":"142","author":"MP Smith","year":"2022","unstructured":"Smith MP. Estimating total morbidity burden of COVID-19: relative importance of death and disability. J Clin Epidemiol. 2022;142:54\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.10.018.","journal-title":"J Clin Epidemiol"},{"issue":"9859","key":"469_CR9","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0140-6736(12)61899-6","volume":"380","author":"CJL Murray","year":"2012","unstructured":"Murray CJL, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(12)61899-6.","journal-title":"Lancet"},{"issue":"10159","key":"469_CR10","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","volume":"392","author":"HH Kyu","year":"2018","unstructured":"Kyu HH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859\u2013922. https:\/\/doi.org\/10.1016\/S0140-6736(18)32335-3.","journal-title":"Lancet"},{"issue":"10258","key":"469_CR11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","journal-title":"Lancet"},{"issue":"10440","key":"469_CR12","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","volume":"403","author":"CJL Murray","year":"2024","unstructured":"Murray CJL. Findings from the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2259\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(24)00769-4.","journal-title":"Lancet"},{"issue":"3","key":"469_CR13","first-page":"495","volume":"72","author":"CJ Murray","year":"1994","unstructured":"Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ. 1994;72(3):495.","journal-title":"Bull World Health Organ"},{"issue":"11","key":"469_CR14","doi-asserted-by":"publisher","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","volume":"3","author":"JA Salomon","year":"2015","unstructured":"Salomon JA, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3(11):e712\u201323. https:\/\/doi.org\/10.1016\/S2214-109X(15)00069-8.","journal-title":"Lancet Glob Health"},{"issue":"7222","key":"469_CR15","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/bmj.319.7222.1423","volume":"319","author":"T Arnesen","year":"1999","unstructured":"Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ. 1999;319(7222):1423. https:\/\/doi.org\/10.1136\/bmj.319.7222.1423.","journal-title":"BMJ"},{"issue":"10440","key":"469_CR16","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","volume":"403","author":"CJL Murray","year":"2024","unstructured":"Murray CJL. Findings from the global burden of disease study 2021. Lancet. 2024;403(10440):2259\u201362.","journal-title":"Lancet"},{"issue":"12","key":"469_CR17","doi-asserted-by":"publisher","first-page":"e1001923-","DOI":"10.1371\/journal.pmed.1001923","volume":"12","author":"AH Havelaar","year":"2015","unstructured":"Havelaar AH, et al. World Health Organization Global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med. 2015;12(12):e1001923-. https:\/\/doi.org\/10.1371\/journal.pmed.1001923.","journal-title":"PLoS Med"},{"issue":"1","key":"469_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijfoodmicro.2013.05.029","volume":"166","author":"JA Haagsma","year":"2013","unstructured":"Haagsma JA, Polinder S, Stein CE, Havelaar AH. Systematic review of foodborne burden of disease studies: quality assessment of data and methodology. Int J Food Microbiol. 2013;166(1):34\u201347. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2013.05.029.","journal-title":"Int J Food Microbiol"},{"issue":"1","key":"469_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10\u201327. https:\/\/doi.org\/10.14740\/wjon1166.","journal-title":"World J Oncol"},{"issue":"11","key":"469_CR20","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold M, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493\u2013505. https:\/\/doi.org\/10.1016\/S1470-2045(19)30456-5.","journal-title":"Lancet Oncol"},{"issue":"10440","key":"469_CR21","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","journal-title":"Lancet"},{"issue":"6","key":"469_CR22","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1158\/1055-9965.EPI-19-1318","volume":"29","author":"H Arem","year":"2020","unstructured":"Arem H, Mama SK, Duan X, Rowland JH, Bellizzi KM, Ehlers DK. Prevalence of healthy behaviors among cancer survivors in the United States: how far have we come? Cancer Epidemiol Biomarkers Prev. 2020;29(6):1179\u201387. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-1318.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10352","key":"469_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","volume":"400","author":"KB Tran","year":"2022","unstructured":"Tran KB, et al. The global burden of cancer attributable to risk factors, 2010\u201319: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10352):563\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(22)01438-6.","journal-title":"Lancet"},{"key":"469_CR24","unstructured":"Surveillance Research Program NCI. SEER* Explorer: an interactive website for SEER cancer statistics. Natl Cancer Inst, 2021."},{"issue":"10125","key":"469_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(17)33326-3.","journal-title":"Lancet"},{"key":"469_CR26","unstructured":"Harrell FE. Regression Modeling Strategies With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis Second Edition Springer Series in Statistics. [Online]. Available: http:\/\/www.springer.com\/series\/692"},{"issue":"7549","key":"469_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332(7549):1080. https:\/\/doi.org\/10.1136\/bmj.332.7549.1080.","journal-title":"BMJ"},{"key":"469_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01635-6","author":"LM Force","year":"2025","unstructured":"Force LM, et al. The global, regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025. https:\/\/doi.org\/10.1016\/S0140-6736(25)01635-6.","journal-title":"Lancet"},{"key":"469_CR29","unstructured":"Percy C, van Holten V, Muir CS, Organization WH. International classification of diseases for oncology. World Health Organization; 1990."},{"issue":"1","key":"469_CR30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12885-020-07079-7","volume":"20","author":"E Torgbenu","year":"2020","unstructured":"Torgbenu E, Luckett T, Buhagiar MA, Chang S, Phillips JL. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis. BMC Cancer. 2020;20(1):604. https:\/\/doi.org\/10.1186\/s12885-020-07079-7.","journal-title":"BMC Cancer"},{"issue":"6","key":"469_CR31","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"469_CR32","unstructured":"Vos T et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019, The lancet, vol. 396, no. 10258, pp. 1204\u20131222, 2020."},{"key":"469_CR33","doi-asserted-by":"crossref","unstructured":"Ellis L, Aur\u00e9lien Belot B, Rachet, Coleman MP. The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival, 2019. [Online].","DOI":"10.1200\/JGO.19.00038"},{"issue":"9064","key":"469_CR34","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498\u2013504. https:\/\/doi.org\/10.1016\/S0140-6736(96)07492-2.","journal-title":"Lancet"},{"key":"469_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-12-18","author":"OF Norheim","year":"2014","unstructured":"Norheim OF, et al. Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Eff Resour Alloc. 2014. https:\/\/doi.org\/10.1186\/1478-7547-12-18.","journal-title":"Cost Eff Resour Alloc"},{"issue":"9","key":"469_CR36","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S2213-2600(21)00164-8","volume":"9","author":"H Ebrahimi","year":"2021","unstructured":"Ebrahimi H, et al. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med. 2021;9(9):1030\u201349.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"469_CR37","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S2213-2600(21)00164-8","volume":"9","author":"H Ebrahimi","year":"2021","unstructured":"Ebrahimi H, et al. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med. 2021;9(9):1030\u201349. https:\/\/doi.org\/10.1016\/S2213-2600(21)00164-8.","journal-title":"Lancet Respir Med"},{"issue":"9859","key":"469_CR38","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","volume":"380","author":"JA Salomon","year":"2012","unstructured":"Salomon JA, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2129\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(12)61680-8.","journal-title":"Lancet"}],"container-title":["Population Health Metrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12963-026-00469-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-026-00469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-026-00469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:29:53Z","timestamp":1776248993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12963-026-00469-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1186\/s12963-026-00469-2","relation":{},"ISSN":["1478-7954"],"issn-type":[{"value":"1478-7954","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}